These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36338294)

  • 1. SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease.
    Yang Q; Xie W; Wang X; Luo J; Zhou Y; Cao H; Sun Q; Jiang L; Yang J
    Front Pharmacol; 2021; 12():707006. PubMed ID: 36338294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
    Su J; Ye D; Gao C; Huang Q; Gui D
    Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice.
    Yang SK; Li AM; Han YC; Peng CH; Song N; Yang M; Zhan M; Zeng LF; Song PA; Zhang W; Tang SQ; Zhang H
    Oxid Med Cell Longev; 2019; 2019():2346580. PubMed ID: 31281569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease.
    Ducasa GM; Mitrofanova A; Fornoni A
    Curr Diab Rep; 2019 Nov; 19(12):144. PubMed ID: 31754839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease
    Wang MZ; Wang J; Cao DW; Tu Y; Liu BH; Yuan CC; Li H; Fang QJ; Chen JX; Fu Y; Wan BY; Wan ZY; Wan YG; Wu GW
    Front Pharmacol; 2022; 13():790937. PubMed ID: 35370636
    [No Abstract]   [Full Text] [Related]  

  • 7. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury.
    Xiao X; Hu Y; Quirós PM; Wei Q; López-Otín C; Dong Z
    Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1318-26. PubMed ID: 24671334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.
    Kravets I; Mallipattu SK
    J Endocr Soc; 2020 Apr; 4(4):bvaa029. PubMed ID: 32232184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormality of renin-angiotensin system in podocyte dysfunction in diabetic kidney disease].
    Shao DC; Lu LM
    Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):246-50. PubMed ID: 22066414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
    Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
    Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
    J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular Endothelial Cell Stress and Cross-Talk With Podocytes in Early [corrected] Diabetic Kidney Disease.
    Daehn IS
    Front Med (Lausanne); 2018; 5():76. PubMed ID: 29629372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SS31 Alleviates Pressure Overload-Induced Heart Failure Caused by Sirt3-Mediated Mitochondrial Fusion.
    Suo M; Qi Y; Liu L; Zhang C; Li J; Yan X; Zhang C; Ti Y; Chen T; Bu P
    Front Cardiovasc Med; 2022; 9():858594. PubMed ID: 35592397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
    Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
    Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
    Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
    J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.
    Ducasa GM; Mitrofanova A; Mallela SK; Liu X; Molina J; Sloan A; Pedigo CE; Ge M; Santos JV; Hernandez Y; Kim JJ; Maugeais C; Mendez AJ; Nair V; Kretzler M; Burke GW; Nelson RG; Ishimoto Y; Inagi R; Banerjee S; Liu S; Szeto HH; Merscher S; Fontanesi F; Fornoni A
    J Clin Invest; 2019 Jul; 129(8):3387-3400. PubMed ID: 31329164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MnSOD Protects against Cold Storage-Induced Mitochondrial Injury but Not against OMA1-Dependent OPA1 Proteolytic Processing in Rat Renal Proximal Tubular Cells.
    Tobacyk J; Kc G; MacMillan-Crow LA
    Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction.
    Liu S; Yuan Y; Xue Y; Xing C; Zhang B
    Front Cell Dev Biol; 2022; 10():832887. PubMed ID: 35321238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y; Ma Y; Xie D; Jiang H
    Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.